PASADENA, Calif, March 27, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ("LIXTE” or the "Company”) (Nasdaq: ...

Discover how SITC's innovative strategies are transforming clinical trials to accelerate the development and approval of ...

The most effective therapies in solid tumors are also the most toxic—and we need to fix that,” says Dr. John Connolly, Chief Scientific Officer of the Parker Institute for Cancer Immunotherapy. In ...

Sandy Weill on Thursday announced a new $50 million donation to create a cancer research and treatment hub focused on ...

The victory totals are starting to swing one local business owner's way as he has positive results in an ongoing battle with lung and brain cancer. Shawn Roehrig, owner of Roland’s Paint and More ...

Bekah Kooy, 38, was convinced she had food poisoning when she felt nauseated and experienced stomach pain following lunch one ...

Recently, the research team led by Professor Zhang Zhongtao and Professor Yao Hongwei from the General Surgery Center at ...

Learn more about the role of Tuberculosis in cancer and how a simple vaccine supports the immune system to fight it.

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

One study showed small cell lung cancer (SCLC) tumors with higher DNA damage response (DDR) activity were initially more sensitive to chemotherapy but had worse overall survival.

“Glioblastoma is the most aggressive primary brain tumor that's known to mankind, and there is no cure for it,” said Dr.

The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory ...